Patents for A61K 49 - Preparations for testing in vivo (35,376)
02/1997
02/12/1997EP0757689A1 Porphocyanine and cnc-expanded porphyrins
02/12/1997EP0757558A1 Screening methods for integumental inflammation modulating agents
02/12/1997CN1142775A Preparation and use of immunoconjugates
02/12/1997CN1142398A Imaging agent for ultrasonic diagnosis for stomach
02/11/1997US5602305 Immunodeficient animal model for studying T cell-mediated immune
02/11/1997US5602299 Express human neurofilament subunit gene, exhibit brain neurofibrillary tangles and pick-like bodies
02/11/1997US5602268 Heating a bi-oxo capped tri-tungsten cluster in the presence of a carboxylate ligand
02/11/1997US5601981 Methods for determining and agents for modulating cellular redox potential and genotoxic states
02/11/1997US5601800 New multifunctional ligands for potential use in the design therapeutic or diagnostic radiopharmaceutical imaging agents
02/11/1997US5601799 Glycoprotein has affinity to macrophages, useage as drug delivery
02/11/1997US5601085 Ultrasound imaging
02/06/1997WO1997003994A1 Tungsten clusters
02/06/1997WO1997003993A1 Process for producing tungsten clusters
02/06/1997WO1997003704A2 In vivo diabetes test
02/06/1997WO1997003697A2 Fluorogenic substrates for diagnosis and photodynamic treatment of tumours
02/06/1997WO1996041144A3 Polyoxyhydrocarbyl marker products and methods for fluorescence assays
02/06/1997WO1996040760A3 Iodine-containing peptides and their use as x-ray contrast media
02/06/1997DE19529922A1 Verwendung von liposomalen Zubereitungen in der indirekten MRT-Lymphographie Use of liposomal preparations in indirect MRT lymphography
02/06/1997DE19529921A1 Mittel zur Ventilations-Bildgebung der Lunge Means for ventilation imaging of the lung
02/06/1997CA2227212A1 Fluorogenic substrates for diagnosis and photodynamic treatment of tumours
02/06/1997CA2225145A1 In vivo diabetes test
02/05/1997EP0756873A2 Radiological, gastrointestinal contrast formulations
02/05/1997EP0756497A1 X-ray contrast compositions containing pharmaceutically acceptable clays
02/05/1997EP0756496A1 Dendrimeric compounds
02/05/1997EP0756495A1 Diagnostic image analysis with metal complexes
02/05/1997CN1142191A Oral magnetic particle formulation
02/05/1997CN1142190A Method and device for the provocation of air passage narrowing and/or the induction of sputum
02/04/1997US5599928 Useful for localization, magnetic resonance imaging, radiosensitization, radiation therapy, fluorescence imaging, and photodynamic therapy
02/04/1997US5599924 Electron-deficient porphyrins and processes and intermediates for preparing same
02/04/1997US5599923 Useful for localization, magnetic resonance imaging, radiosensitization, radiation therapy, fluorescence imaging, and photodynamic therapy
02/04/1997US5599796 Treatment of urogenital cancer with boron neutron capture therapy
02/04/1997US5599720 Binding; quantitative analysis
02/04/1997US5599523 Echo contrast agent
02/04/1997US5599522 Triarylmethyl radicals and the use of inert carbon free radicals in MRI
02/03/1997CA2182636A1 Procedure for obtaining extemporaneous and direct use radiological contrast formulations for gastrointestinal exploration
01/1997
01/30/1997WO1997002842A1 Mr contrast agent
01/30/1997WO1996040279A3 Gas-filled amino acid block co-polymer microspheres
01/29/1997EP0755385A1 Chelant compounds
01/29/1997EP0755373A1 Cyclic triamine chelating agents
01/29/1997EP0755270A1 Microcapsules, method of making and their use
01/29/1997EP0755269A1 Contrast agents
01/29/1997EP0755248A1 Gelified microspheres, method of preparation and applications
01/29/1997EP0755222A1 Microfluidization of calcium/oxyanion-containing particles
01/29/1997CN1141595A Gas-contg. microparticles, agent contg. them, their use in medical diagnosis by ultrasonic tech. and method of producing said particles and agent
01/28/1997US5597699 Method for determining drug compositions to prevent desensitization of cellular receptors
01/28/1997US5597549 Dissolving film forming surfactant and hydrophilic stabilizer in solvent, freeze drying, contacting with air or gas, mixing with aqueous carrier
01/28/1997US5597531 Resuspendable coated magnetic particles and stable magnetic particle suspensions
01/23/1997WO1997002051A2 Cascade polymer complexes
01/23/1997WO1997002050A2 Solid oral diagnostic test meal and methods of use thereof
01/23/1997WO1997002046A2 Saccharide conjugates
01/23/1997WO1996040278A3 Gas-exchange method of making gas-filled microspheres
01/23/1997DE19526561A1 In-vivo-Diabetes-Test In vivo test for diabetes
01/23/1997CA2225959A1 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes
01/22/1997EP0754690A1 Gadolinium-DTPA complex containing carborane unit, intermediates thereof and method of synthesizing them
01/22/1997EP0754680A1 4-Fluoroalkyl-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic as well as medicaments containing them
01/22/1997EP0754677A1 DTPA derivatives modified with non-ester bond an a process for synthesizing them
01/22/1997EP0754032A1 Liquid delivery compositions
01/22/1997EP0754009A1 Magnetic resonance imaging using hyperpolarized noble gases
01/22/1997EP0754006A1 Method and apparatus for diagnosing erectile dysfunction
01/22/1997CN1141059A P53-binding polypeptides and polynucleotides encoding same
01/22/1997CN1141002A Labeled chemotactic peptides to image focal sites of infection or inflammation
01/22/1997CN1141001A Method of storage of ultrasonic gas suspensions
01/22/1997CN1033840C Ultrasonic contrast medium and application for diagnosis treatment
01/21/1997US5595972 Polypeptides for signals
01/21/1997US5595903 Expression vectors, host cells
01/21/1997US5595885 Matrix metalloproteinase inhibitor peptides
01/21/1997US5595737 Leukocyte adhesion molecule, distinction between bound and shed molecule
01/21/1997US5595726 Porphyrin type chromophore conjugated to oligonucleotide, fluorescence, detection of tumors, screening for hiv
01/21/1997US5595725 Relaxation media for nuclear magnetic resonance
01/21/1997US5595724 Treated calcium/oxyanion-containing particles for medical diagnostic imaging
01/21/1997US5595723 Liquid with high vapor pressure dispersed in liquid, ultrasound contrast agents
01/21/1997CA1338854C Oxygenation of blood substitutes
01/20/1997CA2181515A1 4-fluoroalkyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
01/16/1997WO1997001360A2 Compounds with chelation affinity and selectivity for first transition series elements and their use in medical therapy and diagnosis
01/16/1997WO1997001359A2 Metal complexes of polyaminoacids, and their utilization in diagnostic imaging
01/16/1997WO1997001304A1 Radiolabeled apatite particles containing a paramagnetic ion
01/16/1997WO1996035456A3 Use of polymeric contrast agents of medium molecular weight for differentiating between benign and malignant tumours using modern imaging techniques
01/16/1997CA2222697A1 Metal complexes of polyaminoacids, and their utilization in diagnostic imaging
01/15/1997EP0753065A1 Antibodies against e-selectin
01/15/1997EP0752889A1 Liposomes
01/15/1997EP0752873A1 Labelled peptide compounds
01/15/1997EP0652777A4 Small animal metastasis model.
01/15/1997EP0495831B1 Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction
01/15/1997CN1033803C Synthesis of polyazamacrocycles with more than one type of side-chain groups
01/14/1997US5594136 Useful in the separation of neutral and anionic species, phosphate ester hydrolysis, magnetic resonance imaging and photodynamic therapy
01/14/1997US5594022 Carbamates
01/14/1997US5593687 Aqueous dispersion containing liposomes
01/14/1997US5593660 Cascade polymers with iodoaromatic compounds
01/14/1997US5593659 In the form of physiologically acceptable salts; medical diagnosis; water soluble, nontoxic
01/14/1997US5593658 Medical compositions
01/14/1997US5593657 Barium salt formulations stabilized by non-ionic and anionic stabilizers
01/14/1997US5593656 Magnetic resonance imaging
01/14/1997US5592940 Process for making doses formulation of contrast media from concentrate
01/09/1997WO1997000638A2 Apparatus and method for making gas-filled vesicles of optimal size
01/09/1997DE19525924A1 Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel Cascade polymer complexes, process for their preparation and pharmaceutical compositions containing them
01/09/1997DE19524515A1 Saccharid-Konjugate Saccharide conjugates
01/08/1997EP0752473A2 Cloning and characterization of H. pylori flbA gene: production of flagella-free strains
01/08/1997EP0751992A1 Vascular endothelial growth factor 2
01/08/1997EP0551411B1 Ionically cross-linked polymeric microcapsules
01/08/1997EP0374190B1 Spectrophotometric method for quantitatively determining the concentration of a dilute component in a light- or other radiation-scattering environment